No Irenkwshiu the reality was GG offered the convertible to Mesoblast as the company could not do an equity raising before FDA approval. And PK's team had advised a stronger Balance Sheet would help with the FDA approval . GG's convertible offer removed pressure from the share price which almost immediately rallied from 98c to $1.35 and then trended up till FDA approval was granted. Soon thereafter Mesoblast took advantage of the exuberance in Mesoblast's share price to raise capital at $2.50.
But if you want to argue the point argue it with Ecool.
MSB Price at posting:
$1.74 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)